000 01618 a2200481 4500
005 20250516162652.0
264 0 _c20140429
008 201404s 0 0 eng d
022 _a1791-2431
024 7 _a10.3892/or.2013.2640
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLu, Jin
245 0 0 _aIn vivo and in vitro inhibition of human liver cancer progress by downregulation of the μ-opioid receptor and relevant mechanisms.
_h[electronic resource]
260 _bOncology reports
_cOct 2013
300 _a1731-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aDown-Regulation
650 0 4 _aEnzyme Activation
_xgenetics
650 0 4 _aG1 Phase Cell Cycle Checkpoints
_xgenetics
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aJNK Mitogen-Activated Protein Kinases
_xmetabolism
650 0 4 _aLiver Neoplasms
_xmetabolism
650 0 4 _aMAP Kinase Kinase 7
_xgenetics
650 0 4 _aMAP Kinase Signaling System
_xgenetics
650 0 4 _aMale
650 0 4 _aMice, Nude
650 0 4 _aPhosphorylation
_xgenetics
650 0 4 _aRNA Interference
650 0 4 _aRNA, Small Interfering
650 0 4 _aReceptors, Opioid, mu
_xgenetics
700 1 _aLiu, Zefeng
700 1 _aZhao, Lingling
700 1 _aTian, Huimin
700 1 _aLiu, Xiuhua
700 1 _aYuan, Changji
773 0 _tOncology reports
_gvol. 30
_gno. 4
_gp. 1731-8
856 4 0 _uhttps://doi.org/10.3892/or.2013.2640
_zAvailable from publisher's website
999 _c22961542
_d22961542